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The Mid-Atlantic Ethics Committee

Newsletter is a publication of the
Maryland Health Care Ethics
Committee Network, an initiative of
the University of Maryland School of
Law’s Law & Health Care Program.
The Newsletter combines educational
articles with timely information
about bioethics activities. Each issue
includes a feature article, a Calendar
of upcoming events, and a case
presentation and commentary by local
experts in bioethics, law, medicine,
nursing, or related disciplines.
Diane E. Hoffmann, JD, MS
Editor

INVOLVING GREATER PARTICIPATION OF
AN ETHICS COMMITTEE: THE ONLINE
CONSULTATION FORUM

A

s Director of Ethics for Shore
Health System, I have the
privilege – and the challenge – of
leading an active Patient Care Advisory
Committee comprised of talented and
busy professionals who are called upon
to consult on ethics issues that arise in
the delivery of health care for a regional
medical system that covers a four-county
area. The members of the committee
include eight physicians, eight nurses,
a social worker, two case managers, a
chaplain, and two community members
along with the medical librarian, a member of the administration, as well as me
as the Director of Ethics for the healthcare system.
Committee members are involved in
two areas of the committee’s mission:
writing policy and promoting ethics education system-wide. The members also
lend their expertise when requests for
consultation on general topics are submitted to our monthly committee meetings.
We have addressed issues such as elective
Caesarian-sections, mandatory flu vaccinations and requests for non-traditional
practices, just to name a few.
The Patient Care Advisory Committee
members are less available to participate
in clinical bedside consultations. Even
with an on-call procedure in place, I am
often unable to round up members of the
committee for an in-person meeting when
the committee’s assistance is required for
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urgent consultations on patient cases.
On average, the Shore Health System Patient Care Advisory Committee
responds to 140 requests a year. I am the
only member of the committee for whom
ethics consultation is a full-time job. All
of the other committee members have
volunteered to participate on the committee and each of them has other duties,
especially the clinical members. They
often find that they are unable to leave
their full-time jobs to consult on an issue
referred to the committee, especially
when being involved may require traveling 20 to 30 miles to get to one of our
facilities.
The Patient Care Advisory Committee
does participate in retrospective review
of case consultations that have been provided. This approach has several drawbacks. Retrospective reviews do not have
the vitality of real time discussions that
occur as a case itself unfolds. I also find
that reviewing a case after the fact is less
effective as a teaching tool than learning
by doing. Mentoring and learning must
be connected to practice.
I yearned for a way to capture real time
involvement of as many of our committee members as I could in our busy and
complex organization, which includes
two acute care hospitals, a freestanding
emergency center, an acute rehabilitation
unit and several outpatient units.
Cont. on page 2
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Online Consultation Forum
Cont. from page 1
By luck - or perhaps providence - I
chanced upon an article by David
Ramsey, Mary Lou Schmidt, and Lisa
Anderson-Shaw (2010) in the Jounrnal
of Nursing Administration’s (JONA’s)
Healthcare Law, Ethics, and Regulation, “Online ethics discussion forum
facilitates medical center clinical case
reviews.” The authors described their
development and use of a web-based
discussion board with secure access
by their ethics committee members.
The Intranet-based forum was used to
facilitate real time discussion of open
and active ethics consultations within
the University of Illinois at Chicago
Medical Center. They described how
the forum is encrypted and secure and
how it has been in operation for ten
years. I immediately thought that this
forum was exactly what the Shore
Health System Patient Care Advisory
Committee was looking for to encour-

age and broaden the members’ participation in case consultations.
I sent the reference to this article to
the Shore Health System office of Corporate Communications, whose staff
manages the Intranet. I asked our web
experts to read the article and let me
know if they could develop a platform
on which we might create our own
consultation forum. They told me that
this could be done. I then shared the
article with our Patient Care Advisory
Committee and we discussed it at the
next meeting. The committee responded with enthusiasm and encouraged
me to make it happen.
I had a number of discussions with
my Corporate Communications colleagues and the Internet design team
of a local company that supports Shore
Health System’s websites and Intranet.

The Maryland Healthcare Ethics Committee Network (MHECN) is
a membership organization, established by the Law and Health Care
Program at the University of Maryland Francis King Carey School of Law.
The purpose of MHECN is to facilitate and enhance ethical reflection in
all aspects of decision making in health care settings by supporting and
providing informational and educational resources to ethics committees
serving health care institutions in the state of Maryland. The Network
attempts to achieve this goal by:
• Serving as a resource to ethics committees as they investigate
ethical dilemmas within their institution and as they strive to assist
their institution act consistently with its mission statement;
• Fostering communication and information sharing among Network
members;
• Providing educational programs for ethics committee members, other
healthcare providers, and members of the general public on ethical
issues in health care; and
• Conducting research to improve the functioning of ethics committees
and ultimately the care of patients in Maryland.
MHECN appreciates the support of its individual and institutional members. MHECN also welcomes support from affiliate members who provide
additional financial support. Current affiliate members include the Johns
Hopkins Berman Institute of Bioethics.

In just a couple of months, they designed a forum for me to review.
I enlisted the help of two other
members of our Patient Care Advisory
Committee. We went through a testing
and refining period that resulted in a
product presented to the committee,
which includes our Corporate Compliance Officer. The group approved the
forum and we are now using it for our
ethics consultation system-wide.
The forum works easily. I identified
the people who have approved access to the system. They each have a
password that they use to log on to the
home page of the forum. For security
reasons, users must enter their user
name and password each time they enter the forum; they cannot sign in once
and stay logged in indefinitely.
Once a user enters the home page, a
number of actual forums appear. It is
possible to have any number of active
forums on the opening page. Currently
we have four forums:
•

open cases for the calendar year

•

closed cases for the calendar
year

•

a journal club

•

a policy forum for posting
and discussing administrative
policies directly involving the
Patient Care Advisory Committee, such as DNAR, MOLST
and organ transplantation

The Open Case forum contains all
cases that are active and in process.
The cases are identified by date and
time of request, location of the patient,
and a brief description of the nature
of the request (e.g., end of life, code
status, surrogate conflict).
When the case portal is opened, the
first thing that the committee member sees is a fairly detailed description of the case. A template is used,
which includes the date and time of

the request; basic patient identifying
information; location; urgency as defined by the requestor and consultant;
persons involved in the care of the
patient; how the requestor conceives
of the issues at hand; the presence of
an advance directive and a summary
of its contents; code status; family
involvement; background and medical
history; the ethics issues as perceived
by the consultant; involvement of the
patient or surrogates; actions taken;
follow-up and outcomes; date of closing the case; time spent on the case,
including documentation; reflections
for improvement; and the consultant’s
identification.
When a new case is posted in the
forum, members of the committee
receive an email alerting them that a
new case is open and awaiting feedback. Once notified, the committee
members may read the information
on the template and then post comments, questions and suggestions in
a string that appears just below the
opening case information. Each comment that is made in response to the
case is posted with a time stamp and
generates an email that is sent to the
committee members, informing them
that comments have been posted to
the currently active case at hand. This
feature encourages more involvement
and, since it is our experience that a
majority of cases remain open for at
least a day and on average three days,
comments can be posted at any time.
The consultant can also be involved in
the conversation, answering questions,
clarifying points of information and
adding to the original case study as
events may dictate.
When the case is resolved and
closed, a note is posted by me as the
forum administrator in the forum
informing the committee of the case’s
outcome and closing. The case is then

moved to the closed case forum for the
calendar year.
Shore Health System uses an electronic medical record system and the
consultant dictates a summary of the
consultation in the patient’s medical
record. The forum description and
conversation is not placed in the medical record and remains as a resource
for the committee. All consultations
are generated electronically as well
and are sent to my office as the Director of Ethics for the system.
The ethics forum does not replace
in-person consultation and live discussions. However, having this tool
expands the participation of committee
members who may be unable to attend
a meeting as the case unfolds.
Another very important feature
of the forum that we modeled after
the University of Illinois at Chicago
Medical Center is the ability to search
the forum for information that might
be important to the committee. We
can see trends in the types of cases
for which consultations are needed by
grouping the cases by medical issue,
urgency, patient area within the system, and by the identity and role of the
requestor. Because our policy allows
anyone to call for an ethics consultation - nurses, doctors, case managers,
patients and their family members we anticipate that this search function
will be very useful as we use this tool
over time.
I already see many benefits of having this ethics forum in place. The
forum has made it possible for us to
streamline committee meetings since
every member has access to the case
material, which makes it possible to
move through the retrospective review
of cases in a more economical fashion.
The forum also
•

facilitates learning
Cont. on page 4
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Online Consultation Forum
Cont. from page 3
• encourages greater collaboration in case consultations
among all members of the committee
•

allows us to share information
published in the literature via
attachments

•

provides a discussion board
for members to participate in a
journal club

•

gives us access to information that will be of value for an
analysis of our work in general
Brian H. Childs, Ph.D.
Director of Ethics
Shore Health System
University of Maryland Medical
System
Easton, Maryland

REFERENCES
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BioethX LAUNCHING NEW CONSULT MANAGEMENT SERVICE

B

ioethXTM, a Maryland-based
company, is launching the
first commercial Web-based
system to assist healthcare ethics
consultants in their management of
ethics consultations. All that is needed
is a computer with a standard web
browser and an Internet connection.
The system maintains a roster of all
individuals who are authorized and
eligible to become involved in ethics
consultations. Shared access among
designated consultants to a common
repository of information streamlines
communications and allows the inclusion of consultants, no matter where
they are. The system supports notifications via email to ensure timely response and coordination of activities
by advising consultants of referrals,
reminders and planned activities.
A key feature of the system is its
ability to help manage ethics consultations by cueing users to follow

an established workflow process for
orderly execution of activities that
typically lead to well-managed ethics
consults. This guidance can be particularly useful for less experienced
consultants, but for more experienced
consultants or in fast-paced environments, a streamlined process supports
efficient provision of concise consult
information.

Automation of the documentation
process is an advantage over paperbased methods employed by most
organizations today. It supports efficient capture and centralized storage
of key information and online sharing
of that information among involved
consultants. This can greatly improve
the individual productivity of ethics consultants. Simultaneous online
access to shared resources improves
collaboration among staff members,
greatly reducing coordination and
communications overhead activities

and enabling the inclusion of additional participants in a consult for
added expertise and peer validation.
Comprehensive reports can be easily
generated on consulting activities
across an entire facility.

This system provides a secure
portal for information-sharing among
ethics consultants, generates an ethics consultation summary to put in
a patient’s health record (for case
consultations), or to provide to those
who requested a consult, and allows
for tracking consultation performance
and outcomes. All network transmissions are protected by the same
HTTP/SSL encryption widely used
and accepted today for other healthcare applications, e-commerce, and
online banking systems. The service
is fully HIPAA-compliant.
For more information, visit www.
bioethx.net, or contact Ben Martindale at bmartindale@bioethx.net.

COMPLIANCE TOOLBOX WIKI NOW AVAILABLE
Are you interested in Healthcare Compliance and Ethics? Then you will want to visit the Compliance Toolbox
wiki at http://compliance-toolbox.wikispaces.com. Martha Ann Knutson, JD, CHC, developed this wiki after discovering the absence of organized online content on this subject. She also realized that many individuals doing
compliance and ethics in healthcare settings remain isolated in single or slimly staffed departments where they
may not have someone to ask “what do you think?” or “have you seen …”? So, there is a discussion section in the
Toolbox where you can post a question if the wiki doesn’t have an answer to your question. There is also a function
for getting notifications when something is added to the site or to a particular page so that you don’t have to spend
time checking back. This is a non-commercial venture that Ms. Knutson (a former MHECN education committee
member) has developed as her own initiative. Membership is free. Whether you become a member of the wiki or
not, send any feedback on the concept or any ideas you might have to improve it to maknutson@gmail.com.
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MEDICALLY INEFFECTIVE TREATMENT
UNDER MARYLAND LAW:
UPDATE ON MHECN’S EFFORTS TO ADDRESS CONCERNS

M

aryland’s Health Care
Decisions Act (HCDA)
allows two physicians to
certify that a treatment is “medically ineffective” (sometimes called
“futile”) if it will not “prevent or
reduce the deterioration of the health
of an individual,” or prevent “the
impending death of an individual,”
to a reasonable degree of medical
certainty. Such treatment may then be
withheld or withdrawn after certain
procedural steps are followed. In
2009, MHECN surveyed Maryland
adult intensive care unit (ICU) physicians, risk managers, and hospital
attorneys to identify their awareness,
understanding, and interpretation of
Maryland’s HCDA. On November
30, 2010, MHECN held a symposium
to address concerns about differing
interpretations of the law that present
a barrier to withholding or withdrawing medical treatments considered
medically ineffective. Last September, MHECN sponsored a round table
discussion with Maryland hospital attorneys and risk managers to consider
possible solutions to ensure more
uniformity in implementing the law
as regards withholding and withdrawing medically ineffective treatment.
ETHICAL JUSTIFICATION
FOR MEDICAL FUTILITY
LEGISLATION
Empowering clinicians to withhold or withdraw medical treatment
deemed ineffective may be justified
based on concerns that the treatment
may harm the patient (i.e., a “best
interest” ethical standard), that the
treatment may not be what a patient
who previously had decision-making
ability would now want (i.e., a “substituted judgment” ethical standard),
or that providing the treatment may
constitute poor stewardship of limited
health care resources (i.e., a “justice”
ethical standard). Laws regulating

medical futility decisions are directed
toward supporting good medical practice that is fair and consistent across
institutions.
ARGUMENTS IN FAVOR
OF MEDICAL FUTILITY
LEGISLATION
Proponents of medical futility laws
and policies argue that surrogate
decision-makers are unnecessarily
burdened by “false choices” to stop
treatments that are only prolonging their loved one’s death and not
providing a benefit. They consider
requests to “do everything” for a dying loved one as an expected reaction
of grief that should be met with appropriate palliative interventions, and
that succumbing to aggressive end-oflife interventions to appease bereaved
family members at times amounts to
“expensive grief therapy.” Moreover,
health care staff experience moral distress when they provide life support
interventions that they perceive cause
more burden than benefit to dying patients, and that diminish the dignity of
the dying process. Lastly, using ICU
technology on patients who cannot
benefit from it deprives others who
may benefit, and demonstrates poor
resource allocation.
ARGUMENTS OPPOSED
TO MEDICAL FUTILITY
LEGISLATION
Opponents of such laws argue that
less adversarial and more humane
and compassionate approaches are
available to help dying patients and
family members than futility legislation. With good communication,
these requests to continue medically
ineffective/non-beneficial treatment
are rare; as such, a hard line approach
is unwarranted. Futility stand-offs
may be the result of clinicians’ poor
palliative care and end-of-life communication skills, and futility laws

do not provide incentives to physicians to avoid such stand-offs. Also,
clinicians should take responsibility
for determining and implementing the
medical standard of care and not rely
on legislation that provides them with
legal immunity.
HCDA MAIN CONCERNS
The main concerns expressed about
the HCDA relates to the following
provision:
“A health care provider that
intends not to comply with an instruction of a health care agent or a
surrogate shall:
(1) Inform the person giving the
instruction that:
(i) The health care provider
declines to carry out the instruction;
(ii) The person may request
a transfer to another health care
provider; and
(iii) The health care provider
will make every reasonable effort to
transfer the patient to another health
care provider;
(2) Assist in the transfer; and
(3) Pending the transfer, comply
with an instruction of a competent
individual, or of a health care agent
or surrogate for an individual who
is incapable of making an informed
decision, if a failure to comply with
the instruction would likely result
in the death of the individual.”
First: Legal counsel and risk managers at some institutions feel it is
unclear whether a guardian needs to
be appointed to withhold or withdraw
medically ineffective treatment for a
patient who has no identifiable surrogate.
Second: Many are concerned that
Cont. on page 9
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CASE PRESENTATION
One of the regular features of this Newsletter is the presentation of a case considered by an ethics committee and an
analysis of the ethical issues involved. Readers are both encouraged to comment on the case or analysis and to submit
other cases that their ethics committee has dealt with. In all cases, identifying information about patients and others in the
case should only be provided with the permission of the patient. Unless otherwise indicated, our policy is not to identify
the submitter or institution. We may also change facts to protect confidentiality. Cases and comments should be sent to
MHECN@law.umaryland.edu, or MHECN, Law & Health Care Program, University of Maryland Francis King Carey
School of Law, 500 W. Baltimore St., Baltimore, MD 21201.
The following case study and
responses are reprinted with permission from the Handbook for Nursing
Home Ethics Committees, edited by
Diane Hoffmann, Philip Boyle, and
Steve Levenson, and published by the
American Association of Homes and
Service for the Aging in 1995.
CASE STUDY FROM
A NURSING HOME

M

r. Smith, a retired truck
driver, was a seventy-threeyear-old widower and
former World War II prisoner of war.
He had been living in a nursing home
for two weeks. Upon admission, it
was noted that he had several enlarged
lymph nodes in his neck. A history
was taken, and the nursing home physician found that approximately four
years ago Mr. Smith had been treated
for laryngeal cancer with radiation
therapy. The physician immediately
requested an oncology consult. The
oncologist made the decision that Mr.
Smith could remain in the nursing
home for the workup. A CAT (computerized axial tomography) scan
revealed a mass in and around the left
vocal cord, and a biopsy confirmed the
recurrence of the cancer. The oncologist presented Mr. Smith with a choice
of surgery or chemotherapy. Before
Mr. Smith could make a decision, a
woman named Mrs. Adams presented
herself. She announced that she was a
long-time friend of the resident's family and that she was, in fact, the resident's health care proxy, according to
a signed durable power of attorney for
health care, with full decision making
6 Mid-Atlantic Ethics Committee Newsletter

powers regarding all of the resident's
medical treatment. This news raised
the question of the resident's capacity in the progress notes for the first
time. A psychiatric consult revealed
that the resident had the capacity to
make health care decisions. However,
the durable power of attorney document indicated that it went into effect
immediately—not upon the resident's
incapacity.
The oncologist was not sure how to
proceed. He stated that initially Mr.
Smith seemed to prefer the chemotherapy, but when Mrs. Adams refused
to consent to chemotherapy he seemed
"noncommittal" about his treatment in
the sense that he "agreed to anything."
The oncologist indicated that "without
the consent of the medical power of attorney," he would not feel comfortable
giving chemotherapy, even though it
was indicated.
Mrs. Adams called the facility's
social worker out of concern about the
home's efforts to obtain Mr. Smith's
consent for the chemotherapy. She
stated that she knew the resident did
not want chemotherapy, since he had
told her after his earlier radiation
therapy that he did not want "any more
treatments." She said that the resident
was illiterate and had no experience
in making important decisions for
himself. Before her death, his wife had
made all financial and other decisions
for the couple. The wife had made it
clear that Mrs. Adams should assume
and continue these same functions for
Mr. Smith. Mrs. Adams also revealed
that she worked for a private oncologist and knew all about chemotherapy

and that she could not in good conscience consent to such treatment for
Mr. Smith. She would, however, be
willing to consent to the surgery.
How should the nursing home
handle this case?
NOTE: Below, the commentators on
this case use different terms to describe the role of Mrs. Adams—agent,
proxy, and surrogate. Some state
statutes use very specific language to
describe a legally appointed agent—
for example, New York calls them
“health care agents” and Florida calls
them “surrogates.” New York state
calls the document by which an agent
is appointed the health care proxy.
New York state defines a "surrogate”
as a person not legally appointed by
the resident to make health care decisions. Even when similar terms are
used or two different terms seem to be
functional equivalents, it is imperative
that an ethics committee understand
what power a state's law gives to the
term. For example, a "surrogate” in
one state may be able to make any and
all decisions, whereas in another state
a law might limit the kinds of decisions
a surrogate can make—for example,
only decisions that will not end in the
death of the person on whose behalf he
or she speaks.
COMMENTS FROM A HEALTH
LAW PROFESSOR
The significant question in this case
is whether Mr. Smith has the capacity
to make his own health care decisions.
If so, he has the right to make his own
treatment decisions in spite of having
a duly appointed health care agent.
There is nothing in the case which in-

dicates that he lacks decision-making
capacity. Surely, the inability to read
is not a prerequisite for the ability to
make medical decisions. Yet, this case
presents a troubling and confusing
scenario for many health care providers. The confusion comes from having
a legal document—a durable power of
attorney for health care—that clearly
states that the named agent (Mrs. Adams) has the authority to make health
care decisions for the principal (Mr.
Smith).
Legally, a person may execute a durable power of attorney for health care
that takes effect prior to the principal's
incapacity. In Maryland, for example,
the model statutory form provides the
principal with the option of having the
agency take effect upon the principal's
incapacity or when the principal signs
the document. Some individuals—in
particular, those who are elderly and
infirm—want their spouse or child to
make health care decisions for them,
even though they have the capacity to
make health care decisions. They trust
these individuals to make the right
decision for them. They may be too
sick or too weak to concentrate on the
issues, perhaps due to certain sedating
drugs or because they are uncomfortable or in pain.
The appointment often works
smoothly. However, health care
providers are appropriately troubled
when the agent instructs them to do
something that is inconsistent with the
expressed wishes of the principal. As a
legal matter in those cases, the wishes
of the principal take precedent. This
is so for two reasons. First, a principal
can always revoke the appointment of
the agent. Every state's durable power
of attorney for health care statute has
a provision for revocation. In many
cases, the revocation can be accomplished simply by an oral statement
from the principal. Other jurisdictions
require destruction of the original
document or execution of another
document. While this alone is sufficient reason for health care providers
to listen to the principal rather than his

agent, there is also a second reason.
Most state statutes governing health
care agents provide that these agents
must make a decision that is consistent
with the resident's known wishes. The
agent is not to make a decision that is
at odds with the resident's expressed
wishes.
In this particular case, there is a third
reason to be skeptical of Mrs. Adams's
role. It is not totally clear whether the
original durable power of attorney is
valid, for it is questionable whether
Mr. Smith actually understood what he
was signing and whether he agreed to
it. Mrs. Adams states at one point that
Mr. Smith's wife had made it clear before her death that Mrs. Adams should
continue to make the same type of
important decisions for Mr. Smith as
Mrs. Smith had. There is no indication
that these were Mr. Smith's wishes,
and the fact that he cannot read raises
questions about his full understanding
of the document he signed.
While this case is rather straightforward as a matter of law, as a practical
matter it is still problematic. Mr. Smith
appears somewhat intimidated by Mrs.
Adams and seems to defer to her. As a
result, even if the agency is revoked,
Mr. Smith may still be influenced by
Mrs. Adams. Some effort needs to be
made to speak with Mr. Smith alone
and explain to him his right to make
his own health care decisions. This
alone may not be sufficient to get
him to make an independent decision, especially if he feels in any way
dependent on Mrs. Adams for further
care. Therefore, someone from the
facility also needs to talk to Mrs.
Adams and explain to her the limits
of her authority and the rights of Mr.
Smith to make his own decisions. She
may feel as though she is protecting
Mr. Smith from the "medical establishment," given her experience working
for an oncologist, and she may feel
that the oncologist in this case is not
being fully honest with Mr. Smith. As
a result, it might be helpful if someone
who is not from the medical staff, such
as the facility administrator or clergy,

speaks to Mrs. Adams.
The personal dynamics in this case
appear more troublesome than the
actual legal or ethical problem. We are
not privy to the historical or current relationship between Mr. Smith and Mrs.
Adams. This information is essential
to understanding how Mr. Smith
views his choices in this case. A social
worker or someone trained in counseling skills may be helpful in getting
Mr. Smith to describe his relationship
with Mrs. Adams and why he appears
intimidated by her. If such information
can be obtained, steps might be taken
to alleviate Mr. Smith's concerns. If
not, the nursing home must continue
to confer with Mr. Smith and follow
his instructions—even allowing him to
defer to Mrs. Adams if he fully understands the implications of that choice.
Diane E. Hoffmann, JD, MS
Director, Law & Health Care Program
& Professor of Law
University of Maryland
Francis King Carey School of Law
COMMENTS FROM A
RELIGIOUS STUDIES
PROFESSOR
This case underscores the importance of identifying surrogates or
proxies and involving them in care
planning as soon as possible. The sudden appearance of Mrs. Adams turns
Mr. Smith passive, halts his planned
chemotherapy treatment, and presents
the nursing home with some questionable explanations to sift through. Mrs.
Adams's rationale for refusing chemotherapy is not only inconsistent in
itself, but at variance with Mr. Smith's
own preference. In short, Mr. Smith's
personal values and his best interests
may well be jeopardized by Mrs.
Adams's decision making. The nursing home is dealing with a potentially
undependable proxy.
Mrs. Adams's primary obligation is
to make treatment decisions reflecting Mr. Smith's own preferences. In
Cont. on page 8
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Case Presentation
Cont. from page 7
the absence of stated preferences, her
decisions should be guided by Mr.
Smith's basic values and beliefs. Moreover, Mr. Smith still has decisionmaking capacity. (Despite what Mrs.
Adams implies, his illiteracy does not
constitute decisional incapacity.) Mrs.
Adams can elicit Mr. Smith's actual
preferences for treatment. There is,
however, no indication that she does
so. She has played no active role in
Mr. Smith's admission to the nursing
home or in the subsequent decisions to
proceed with a diagnostic work-up and
biopsy. Her lack of contact with Mr.
Adams is made more troubling by the
revelation that she was named proxy
not by Mr. Smith himself, but by his
now deceased wife. On the whole,
Mrs. Adams does not seem to have
the kind of ongoing contact with Mr.
Smith that would make her a wellinformed proxy.
Moreover, her explanation for
refusing chemotherapy is disturbingly
inconsistent. She bases the refusal
on Mr. Smith's statement, four years
earlier, that he did not want "any more
treatments." Yet she indicates that she
would consent to surgery—certainly a
"treatment," perhaps even more drastic
than chemotherapy. She further clouds
her refusal by saying she has worked
for an oncologist and knows "all
about" chemotherapy. Her announced
certitude here suggests that she will
not seek medical advice for Mr. Smith,
much less weigh it seriously. In sum,
her failure to elicit Mr. Smith's present
wishes, her dismissal of his decisionmaking ability, and her absolutist stand
about oncology all suggest a poorly
informed, potentially coercive proxy.
On the other hand, proxies need not
be "perfectly" rational, expertly informed, medically "obedient" decision
makers, any more than the residents
they represent. Biased, informationresistant, potentially coercive proxies
can function validly—up to a point.
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Determining that point is, of course,
a critical task for care providers. The
rights and powers of proxies are not
absolute. The obligations of care
providers to respect residents' preferences and to pursue their best interests
should not be abrogated by a dubious
proxy. And Mrs. Adams is perilously
close to being dubious.
The oncologist's reactions too are
morally questionable. His temporizing suggests legalistic paralysis more
than moral caution. If the oncologist
is inhibited by Mrs. Adams's refusal
of consent, the nursing home should
not be. The home should engage Mr.
Smith in further conversation to clarify
the reasons behind his initial choice of
chemotherapy and his later vagueness
when Mrs. Adams vetoes the treatment. The nursing home should also
make sure that Mr. Smith recognizes
his rights to determine his own care
and to reject or accept Mrs. Adams's
surrogacy. Certainly, the home's administrators should ask how he wants
them to proceed when Mrs. Adams
makes decisions that run counter to his
own preferences.
Full and open communication with
Mrs. Adams would also be essential. It
would provide the nursing home with
an opportunity to voice its concern
that she has overridden Mr. Smith's
stated preference and that her explanations for this are troubling. Discussion
of this sort might stir some second
thoughts in Mrs. Adams and might
give the nursing home a better understanding of her style of surrogacy.
If no deeper mutual understanding
results, the home should be ready to
take whatever formal action might be
necessary to challenge Mrs. Adams's
decision in this particular instance and
perhaps to challenge the appropriateness of her being a proxy altogether.
In dealing with this case, the nursing
home's staff will be helped immensely
if the facility has clear policies and
procedures for dealing with conflicts

that arise around surrogate/proxy
decision making. The home's ethics
committee should have a clear role
in making and reviewing such policy
and in carrying out the education that
would make it effective. In particular,
an ethics committee looking at this
case retrospectively might want to examine its facility's admissions process,
especially in light of the Patient SelfDetermination Act (PSDA).
A minimalist response to the PSDA
requires only the formality of a question about the existence of an advance
directive. A full-fledged response,
however, would call for an in-depth
exchange about the content of the
directive and the identity of any surrogates named (Johnson, 1991). Such an
exchange might have uncovered Mrs.
Adams's proxy status (and its potential
problems) at a much earlier point. The
committee might also feel the need for
educational work with staff members on questions relating to advance
directives. Mr. Smith has executed an
"immediate" durable power of attorney
and not the more common "springing" durable power of attorney (which
would go into effect only in the event
of his decisional incapacity) (New
York State Task Force, 1987). It would
be especially crucial for nursing home
staff to know about this type of agency
since it is active even when a resident
has decision-making capacity. For that
reason it can seriously complicate the
decision-making process—as this case
amply indicates.
Bart Collopy, PhD
REFERENCES
Johnson, S. (1991). “PSDA in the
Nursing Home,” in “Practicing the
PSDA,” special supplement, Hastings Center Report, 21(5), 53-S4.
New York State Task Force on Life
and the Law (1987), Life-Sustaining
Treatment: Making Decisions and
Appointing a Health Care Agent, pp.
95-100; see p. 41.

MHECN PROGRAM COORDINATOR ANITA TARZIAN RECEIVES AWARD
On October 15, 2011, MHECN’s Program Coordinator Anita J. Tarzian, PhD, RN was awarded The Distinguished
Service Award from the American Society for Bioethics and Humanities (ASBH). Dr. Tarzian’s service to ASBH
over the years has included serving as a Board Member at Large (2002-2004), as
Board Secretary (2004-2008), and currently, as Chair of the Clinical Ethics Consultation Affairs (CECA) Standing Committee. CECA recently published a report with
recommendations to the ASBH Board regarding whether and how to certify ethics
consultants and accredit programs that train them. It also advises the Board on issues related to health care ethics and standards for ethics consultation. In addition,
ASBH recognized Dr. Tarzian’s service as Chair of the Core Competencies Update
Task Force, which produced the second edition of the report, Core Competencies for
Health Care Ethics Consultation (published by ASBH in 2011).
As Program Coordinator of MHECN, an initiative of the University of Maryland
School of Law, Dr. Tarzian serves as a resource for health care ethics committee
members in Maryland and the mid-Atlantic region. A former surgical oncology nurse
Anita J.
and hospice nurse, she is currently Associate Professor at the University of Maryland
Tarzian, PhD, RN
School of Nursing in the Department of Family and Community Health. Her professional focus has been in clinical and research ethics, including clinical ethics consultation in acute and long-term
care settings, ethics education, palliative care, hospice, the influence of culture on health care decision-making, and
disability rights. Dr. Tarzian received a Doctorate in nursing research (ethics track) and a Masters in Intercultural
Nursing from the University of Maryland School of Nursing, a Bachelor of Science in Nursing from Rush University, and a Bachelor of Arts from Knox College.

Medically Ineffective Treatment
Cont. from page 5
there is no limit to how long treatments need to be continued pending transfer, since in most situations
where clinicians decide that particular
interventions are medically ineffective,
there is no transfer option.
PROPOSED SOLUTION
Jack Schwartz, JD, Adjunct Professor at the University of Maryland Francis King Carey School of
Law and former Maryland Assistant
Attorney General, has proposed a
solution through rule-making through
the Department of Health and Mental Hygiene (DHMH). Assuming
that DHMH might be open to this
approach, which is speculative at
present, this option would involve
elevating certain Attorney General
opinion letters to regulatory status. For
example, one opinion letter states that
if there is no identifiable surrogate to
notify regarding a decision to with-

hold or withdraw medically ineffective
treatment (after reasonable efforts to
locate a surrogate have been made),
it is not necessary to appoint a guardian simply to have someone to notify.
In addition, such regulations might
clarify how long to maintain interventions deemed medically ineffective
pending transfer. At the attorney/risk
manager round table last September,
most attendees supported this approach. Thus, efforts are underway to
draft this regulatory language.
ONE PART OF A BIGGER
PICTURE
Medical futility laws are most often
invoked for individuals whose death is
impending, where a question is raised
about the ability of aggressive lifeprolonging interventions to achieve a
benefit for the patient. What is clear is
that such individuals deserve excellent
palliative care, which includes com-

fort care and psychospiritual support
(the latter for both the patient and his
or her loved ones). All clinicians are
obligated to ensure that patients have
access to excellent palliative and endof-life care, regardless of whether the
patient’s dying process is prolonged
through medical technology. Taking
“false decisions” off the shoulders
of surrogate decision-makers is good
medical practice. Maryland’s HCDA is
intended to support that process, but it
cannot replace good medical practice.
Toward that end, more education is
needed for health care professionals,
legal guardians, attorneys, risk managers, and the public to ensure that state
legislation and regulation supports
best medical practice.
If you have questions about these
efforts, contact MHECN Program Coordinator Anita Tarzian at atarzian@
law.umaryland.edu.
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MARYLAND MOLST UPDATE
DHMH's rulemaking, which is needed to complete the process of getting MOLST into final legal form, is still pending. The comment period has closed, and as of this writing DHMH continues to evaluate the comments. Meanwhile,
MOLST has already come into voluntary use across the state. Many health care facilities and programs are finding
that MOLST is a very useful tool for carrying out already established legal and ethical obligations. In addition,
MIEMSS accepts MOLST as the equivalent of an EMS/DNR order. Therefore, although the use of MOLST is not
yet legally required, its voluntary use now may be valuable in framing conversations with patients and their families
about care planning and in documenting the clinical steps needed to carry out care plans. A wealth of MOLSTrelated information and training aids may be found on this DHMH website: http://dhmh.md.gov/marylandmolst/

FEBRUARY

CALENDAR OF EVENTS

8
End-of-Life Nursing Care Workshop. ELNEC-based course sponsored by the University of Maryland Medical Center’s Office of Clinical Practice and Professional Development. Paca Pratt Learning Center, Room 7A,
UMMC, Baltimore, MD. For more information, contact kgorman@umm.edu.
13 (1-2PM)
Embracing Cultural Diversity in Medical Practice. Sponsored by the UMMC Ethical Advisory Committee.
University of Maryland Medical Center, 22 S. Greene St., Baltimore, MD, Shock Trauma Auditorium. For more
information, contact Hsilverm@medicine.umaryland.edu.
16 (6-7:30PM)
The Ethics of Erasing Memories “Eternal Sunshine” Style. Speaker Matthew Liao, Ph.D., Center for Bioethics,
New York University. Columbia University Morningside Campus, New York, NY. To RSVP or for more information, contact Meghan Sweeney at ms4184@columbia.edu.
MARCH
4 (6 PM)
“Am I My Genes?” Sphinxes, Chimeras, & Other Mixes of Species in Science & Art. Speaker Robert Klitzman,
MD, Dept. of Psychiatry, CUMC, Guggenheim Works & Process Series. Solomon R. Guggenheim Museum, 1071
5th Ave. (at 89th St. ), New York, NY. For more information, contact ms4184@columbia.edu.
13-14
Mixed Messages: Ethical Tensions in Healthcare Conversations. Sponsored by the Health Care Ethics Consortium
of Georgia (HCECG) and the Emory University Center for Ethics, at the Emory University Center for Ethics,
Atlanta, Georgia. For more information, visit www.hcecg.org, or call 404-727-9533.
15 (6-7:30 PM)
Speaker Oliver Sacks, MD, Low 207, Columbia University Morningside Campus, Columbia University, New
York, NY. To RSVP or request more information, contact Meghan Sweeney at ms4184@columbia.edu.
16
Ethics of the Heart II: Ethics and Policy Challenges in Congenital Heart Disease. Sponsored by the Penn Cardiovascular Institute, the Cardiac Center at the Children's Hospital of Philadelphia (CHOP) and the Center for
Bioethics at the University of Pennsylvania. CHOP, Philadelphia, PA. For more information, contact james.
kirkpatrick@uphs.upenn.edu.
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CALENDAR OF EVENTS (cont'd)

30-April 1
“The Significance of Neuroscience for Morality: Lessons from a Decade of Research” (Part I), and
“Can Moral Behavior be Improved or Enhanced?” (Part II). Sponsored by the NYU Center for Bioethics, Duke
Kenan Institute for Ethics, Yale Interdisciplinary Center for Bioethics, and the Institute for Ethics and Emerging
Technologies. New York University, WSQ Campus (room TBA). For more information, contact bioethicsconference@nyu.edu or visit http://bioethics.as.nyu.edu/object/bioethics.events.20120330.conference
APRIL
12-13
New Technologies, New Challenges: Women and Prenatal Genetic Testing in the 21st Century. Jointly Sponsored by the Department of Bioethics at the Cleveland Clinic and the Center for Genetics Research, Ethics and
Law at the Case Western Reserve Medical School. Case Western Reserve University School of Law, Cleveland,
OH. For more information, visit http://www.law.case.edu/Lectures.aspx?lec_id=295, or call 216-368-1798 (tollfree 888-814-5878).
17 (12-1:15P)
Advance Care Planning: Addressing the Gaps between Knowledge and Practice. Speaker: Myra J. Christopher,
Center for Practical Bioethics. Annual Shallenberger Lecture in Ethics, sponsored by the Johns Hopkins Hospital Ethics Committee and Consultation Service. For more information, contact Sharon Mears at smears@jhmil.
edu, 410-955-0620.
26-27
Borders and Barriers: Mapping a Moral Path. This conference will have a Hot Topics track that will focus on
high profile issues in the healthcare headlines and an Issues in Practice track that will focus on applied topics for
individual and ethics committee development. Sponsored by the Colorado Healthcare Ethics Forum. Stonebrook
Manor Event Center and Gardens, Thornton, Colorado. For more information, visit http://coloradoethicsforum.
org/
MAY
1-3
Ethics Education in a Global Perspective. Inaugural International Conference on Education in Ethics. Organized
by the International Association for Education in Ethics (IAEE) and the Center for Healthcare Ethics. Duquesne
University, Pittsburgh, Pennsylvania. For more information, visit http://www.duq.edu/healthcare-ethics/iaee/, or
e-mail iaee@duq.edu.
10-11
Reforming Ethics and Humanities Teaching in Medical Education: Fulfilling Future Accreditation Goals on
Professionalism. Sponsored by the Romanell Fund for Bioethics Pedagogy at the University at Buffalo and the
University of Louisville. The Brown Hotel, Louisville, KY. For more information, visit www.primemedicine.
org.
15-16
Hospitals, Healthcare, and the Medical Humanities. Sponsored by Children's Hospital of Pittsburgh, 4401 Penn
Avenue, Pittsburgh, PA. For more information, contact meeting Lisa Parkera (lisap@pitt.edu) or Valerie Satkoskeab (vbv2@pitt.edu).
31-June 1
Third Annual Conference of the International Society of Advance Care Planning and End of Life Care. For more
information, visit http://www.acpelsociety.com/conference/.
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